Brief: Bone Biologics Regains Compliance With Nasdaq Continued Listing Requirements
10/01/2024 13:16
Jan 10 (Reuters) - Bone Biologics Corp BBLG.O :
* BONE BIOLOGICS REGAINS COMPLIANCE WITH NASDAQ CONTINUED
LISTING
REQUIREMENTS
Source text for Eikon: ID:nBw6FfbHXa
Further company coverage: BBLG.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bone Biologics
See all newsBone Biologics Corp expected to post a loss of 39 cents a share - Earnings Preview
Brief: Bone Biologics Extends Rhnell-1 Shelf Life To 24 Months
Brief: Bone Biologics CEO Issues Letter To Stockholders Highlighting Company Update And Outlook
Bone Biologics Corp expected to post a loss of 53 cents a share - Earnings Preview
Bone Biologics Corp expected to post a loss of 58 cents a share - Earnings Preview